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Background: Congenital hearing loss is one of the most frequent birth defects, and Early Detection and
Intervention has been found to improve language outcomes. The American Academy of Pediatrics (AAP) and the
Joint Committee on Infant Hearing (JCIH) established quality of care process indicators and benchmarks for
Universal Newborn Hearing Screening (UNHS). We have aggregated some of these indicators/benchmarks
according to the three pillars of universality, timely detection and overreferral. When dealing with inter-comparison,
relying on complete and standardised literature data becomes crucial.
The purpose of this paper is to verify whether literature data on UNHS programmes have included sufficient
information to allow inter-programme comparisons according to the indicators considered.
Methods: We performed a systematic search identifying UNHS studies and assessing the quality of programmes.
Results: The identified 12 studies demonstrated heterogeneity in criteria for referring to further examinations
during the screening phase and in identifying high-risk neonates, protocols, tests, staff, and testing environments.
Our systematic review also highlighted substantial variability in reported performance data. In order to optimise the
reporting of screening protocols and process performance, we propose a checklist. Another result is the difficulty in
guaranteeing full respect for the criteria of universality, timely detection and overreferral.
Conclusions: Standardisation in reporting UNHS experiences may also have a positive impact on inter-program
comparisons, hence favouring the emergence of recognised best practices.
Keywords: Neonatal screening, Process assessment (Health Care), Quality indicators, Health care, Benchmarking,
ChecklistBackground
The prevalence of sensorineural hearing loss ranges from
0.1 to 0.3 % for newborns [1–5] (2 to 5 % with the pres-
ence of audiological risk factors) [6]. In the absence of
newborn screening, parents can only observe their infant
for any inattention or unresponsiveness to sound [7, 8],
often leading to delayed diagnosis of hearing loss until age
14 months on average [9]. This delay results in impaired
language, learning, and speech development [10, 11], with* Correspondence: pierpaolo.mincarone@irpps.cnr.it
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creativecommons.org/publicdomain/zero/1.0/lifelong consequences [12] including associations with in-
creased behaviour problems, decreased psychosocial well-
being, and poor adaptive skills [13–15]. Identification of
hearing impairment in early childhood allows early inter-
vention during a ‘sensitive period’ for language develop-
ment [16]. More than half of babies born with hearing
impairment do not have prospectively identifiable risk fac-
tors, so only universal newborn hearing screening (UNHS)
programmes can identify the majority of those affected
[17]. UNHS is performed via otoacoustic emission (OAE)
and/or automated auditory brainstem response (aABR)
testing. Neonates with positive tests are referred to audio-
logical full evaluations for diagnosis. Children with con-
firmed hearing loss are managed according to earlyss article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Mincarone et al. BMC Pediatrics  (2015) 15:86 Page 2 of 12intervention strategies, which depend on the identified
aetiology and may be divided into the following broad cat-
egories: audiological, medical/surgical management; edu-
cational and (re)habilitation methods; and child and
family support [18].
The benefits of UNHS have been highlighted in two
published systematic reviews. Nelson and colleagues [19]
found that children with hearing loss identified through
UNHS obtained better language outcomes at school age
than those not screened, and that screened infants iden-
tified with hearing loss had significantly earlier referral,
diagnosis and treatment than those not screened. Wolff
and colleagues [20] determined that early identification
and treatment were associated with improved long-term
language development. More recently, numerous obser-
vational cohort studies [17, 21–23] have shown that
early detection and intervention improve long-term
reading and communication abilities when compared
with no screening or late distraction hearing screening.
Differences between countries in terms of healthcare
systems and the availability of resources and personnel
to implement hearing screening programmes result in
different approaches to implementation. Evidence from
successful newborn and infant hearing screening pro-
grammes indicates several factors associated with better
outcomes [24]. These include but are not limited to the
following: a clearly defined and documented screening
protocol; regular monitoring to ensure correct imple-
mentation of the protocol; specific training for the staff
conducting the screening; quality-assurance procedures
implemented to show when results are not consistent
with expectations and to track what happens to all those
who do not pass the screening [24].
In 1999 the American Academy of Pediatrics (AAP)
Task Force on Newborn and Infant Hearing [9] formally
supported the Joint Committee on Infant Hearing (JCIH)
position [25] to prevent these adverse consequences
through universal screening and detection of newborns
with hearing loss before 3 months of age and intervention
by 6 months of age, as recommended by the National
Institutes for Health [26]. The JCIH recommendations
[27, 28] form the basis for Universal Newborn Hearing
Screening (UNHS) programmes developed worldwide and
implemented routinely through national legislation, re-
gional provisions or single health enterprise/hospital
initiatives. Following the 1999 AAP Task Force [9], the
2000 JCIH Position Statement [27] established process
and outcome performance benchmarks for Early Hearing
and Detection Intervention (EHDI) programmes to evalu-
ate UNHS progress [29] and determine programme
consistency and stability [30]. Any programme not meet-
ing these quality benchmarks should identify sources of
variability and improve its processes [31]. The JCIH also
suggested that hospitals and state programmes establishperiodic review processes to re-evaluate benchmarks as
more outcome data becomes available [27]. In 2007 [28],
together with an updating of the proposed indicators for
quality measure, the JCIH recommended timely and
accurate monitoring of relevant quality measures as an
essential practise for inter-programme comparison and
continuous quality improvement.
Starting from the available statements [9, 27, 28], we
have aggregated some of the already available indicators/
benchmarks to evaluate the process quality of a hospital-
based UNHS programme according to its three pillars of
universality, timely detection and overreferral. The pro-
posed aggregation reflects the need to measure the
performance of screening programs with respect to
population coverage, prompt diagnosis and consequent
activation of therapeutic strategies, impact on resource
consumption and stress for parents and families.
An efficient way to favour inter-programme compari-
son is to rely on complete and standardised literature
data (avoiding, for example, the burden of contacting au-
thors to retrieve unpublished information) and so we
performed the present study to verify whether literature
data reporting experiences of UNHS programmes in-
cluded sufficient information to allow inter-program
comparisons according to the proposed indicators.
Methods
Protocol
We conducted a systematic literature search to identify
studies on hospital-based UNHS programmes. State-
wide EHDI programmes were not taken into account.
These studies (in English) were identified by searching
electronic databases, scanning reference lists of articles
and consultation with experts. We excluded articles
without a screening protocol description, unequivocal
assignment of results to the described protocols when
more than one was used, or presence of the results of a
full audiological evaluation (assumed as the reference
gold standard). When different publications on the same
cohort were identified, only the most recent was consid-
ered, with analysis of the previous ones if relevant to re-
trieve missing information. Databases searched included
Ovid MEDLINE (R), EMBASE, CINHAL, Cochrane
Library, and Science Citation Index (Web of Science).
The search was applied, from 1990 to 2014 (last search
February 5th, 2014) and an additional exclusion criterion
was introduced, after the full-text screening phase, in
order to limit the analysis to articles submitted after the
publication of the first JCIH position statement (October
2000) [27] with quality indicators and benchmarks. The
year 2000 was a plausible cut-off date, even with the
2007 JCIH criteria, as no additional indicator was added
in the 2007 JCIH position statement with respect to the
ones either suggested by the AAP in 1999 or by the
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cluded: child*, infant*, neonate*, newborn*, new born,
paediatri*, pediatric*, hearing disorders, hearing impair*,
hearing problem*, hearing defect*, hearing los*, deaf*,
paracus* and dysacus*, and screen*. A fourth category of
inclusion criteria was related to the study design in
order to include multi-centre, observational and other
types of clinical trials dealing with evaluation of
programme efficacy.
Additional file 1: Appendix 1 provides the detailed
search strategy. FC developed the search strings for each
single database, interrogated the repositories and cleaned
from duplicates. Two reviewers (PM, CGL) independ-
ently assessed abstract and full text eligibility with dis-
agreements resolved by consensus (CGL, PM, SS, DC,
JBW and GL).
This research did not involve human subjects.
The review is reported according to the Prisma
Statement [32].Quality indicators and benchmarks
As suggested by the WHO, benchmarking of UNHS, i.e.
evaluation of the programme against a set of quality
standards, should include the minimum participation
rate at screening; age at completion of the screening
process; maximum referral rate; minimum participation
rate and age at completion of diagnostic testing [24].
We assumed as reference indicators and benchmarks
the one proposed by the AAP and JCIH whose statements
are milestones recognised worldwide in the development
of UNHS programs. Such indicators fulfil the WHO indi-
cations for UNHS programme monitoring [24].
We grouped the AAP [9] and JCIH [28] quality indica-
tors and related benchmarks into three main aspects for
assessment (Table 1):
1) Universality – measured in terms of coverage of the
population in both recruitment and follow-up
phases
2) Timely detection – evaluated according to the
observed prevalence (influenced by false negatives)
and the average time for diagnosis
3) Overreferral – estimated by referral rates in key
phases of the screening programme.Data extraction
Pre-specified extracted information included: (1) type of
study, description of programme parameters, methods
for risk assessment, tests used, positivity criteria (screen-
ing threshold levels [dB] and unilateral vs. bilateral hear-
ing loss used for the screening tests), environmental test
conditions, types of personnel performing the test; (2)
quality indicators. Two authors (CGL, PM) separatelyextracted data from each included study. Disagreements
were resolved by discussion among the authors.
The authors of the selected articles were contacted
whenever there was a need to obtain additional details
on the reported data.
Results
We identified 1,641 citations with eight additional cita-
tions from hand-searching personal literature files and ref-
erence lists, yielding 1,649 in all but only 1,151 non-
duplicate citations. After abstract review, 90 met criteria
for full text retrieval, and of these, 12 articles [33–44] met
criteria for full analysis (Additional file 2: Figure S1); these
include two studies [35, 38] that reported only on neonates
without risk factors but were included since those were
part of a UNHS programme. The following authors were
contacted for additional details: Calevo [34] to specify
whether the second ABR test considered was automatic or
diagnostic; Guastini [37] to clarify the false-positive rate
of the fourth stage considered in their programme;
Kennedy [39] for clarifications on lost to follow-up; Lin
[41] for clarifications on the full audiological evaluation
phase. All the information provided was considered in
the present work.
Table 2 describes the selected articles. The only con-
trolled clinical trial of UNHS and the 8-year follow-up
resulted in a publication also based on a preliminary
report published 7 years earlier [39, 40].
Audiological risk classification was based on different
criteria: JCIH recommendations [33, 34, 36, 38], and ad-
hoc criteria; [37, 39, 42, 43] four studies provided no de-
tails on this point. [35, 40, 41, 44] One of the studies
using JCIH criteria did not use the most recent guide-
lines available at the start of their recruiting period [34],
and another one [36] reported using a standard that was
unavailable at the start of their recruitment.
In our analysis, any examination subsequent to the
first one was considered to comprise part of the follow-
up phase (Fig. 1 displays the framework used for char-
acterising the screening processes in each study).
Screening examinations were carried out with one or
more of the following: transient evoked otoacoustic
emission (TEOAE), and/or auditory brainstem response
(ABR). Although most studies use automated ABR
(aABR) for screening, in three cases [34, 36, 37], diag-
nostic ABR (dABR), usually part of the final definitive
audiological evaluation, was included within initial
screening to gain additional qualitative and quantitative
information about auditory nerve and brainstem path-
way function. Hence, for our study we used ABR to
refer to both aABR and dABR screening. In Lin and
colleagues [41], dABR was performed at age 1 month,
with all other gold standard examinations performed at
age 3–6 months. Screening programmes involved a
Table 1 Quality indicators and related benchmarks assessed in our study
ID Indicator Benchmark Source Numerator Denominator Dimension




Number of neonates that
have a hearing screening
test by 1 month of age
Number of neonates Universality
Percentage of newborns
who complete screening
by 1 month of age




Number of neonates positive at
the first screening test minus
neonates who do not complete
further testing (lost to follow-up)
Number of neonates positive
at the first screening test
Universality
Follow-up rate




Number of neonates undergoing
definitive audiological evaluation









evaluation by 3 months
of age








Number of screened neonates
with audiological risk factors










4b Low-risk measured prevalence Not available
(N.A.)
N.A. Number of screened neonates
without any audiological risk factor



















Number of screened neonates
(with and without audiological risk




neonates with or without
audiological risk factors (at
net of the lost to follow-up)
Timely
detection
Observed prevalence for whole
population







Number of screened neonates
with a positive test at the last





Referral rate before leaving the
hospital
b) 4 % (when
ABR is also
used)







Number of children sent to a
definitive audiological evaluation
Number of screened
neonates (at net of all those
lost to follow-up)
Overreferral
Percentage of all newborn infants
who fail initial screening and fail
any subsequent rescreening before
definitive audiological evaluation;
the recommended benchmark is
less than 4 %.




Number of neonates with positive
test at last screening test who





(false positive plus true




False-positive rate related to the
entire screening process
aAmerican Academy of Pediatrics
bWhen the true negatives are not available we have considered that all the negatives (i.e., all the screened minus the true positives and minus the lost to
follow-up) are true negatives
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[36, 41, 42] or four [34, 37, 40] examinations prior to
definitive audiological evaluation and in six cases
[33, 35, 38, 39, 41, 44] no distinction was reported for
neonates with audiologic risk factors.
These 12 published studies reported on 14 screening
protocols (Table 2) because during separate time frames,one study [36] reported three different protocols (only
TEOAE, only ABR and both). Only otoemission was
used in five protocols [33, 38, 40, 41, 43], only ABR in
three [35, 41, 44] and both techniques in six [34, 36,37,
39, 41, 42]. For neonates staying in NICU for more than
5 days, five protocols [35–37, 41, 44] (the “c” protocol in
Lin et al. [41]) screened with ABR as recommended by
Table 2 Study description and protocol used






















to 2007 + 36 m
JCIH 2007 1 Hospital OAEa 1; 1; 2 40 dB HL; unilateral Audiologist Non-sound-treated
room (average noise
< 45 dB)





JCIH 1994 13 Hospitals Bothb 1; 3; 4 50 dB SPLb,c; unilateral N.R. Sound-proof and
faradized room
3 Cebulla M, 2012 [35] –
Germany - Hospital-
based series
2006, March + 60 m N.R. 1 Well baby nursery -
University maternity
clinic








4 De Capua, 2007 [36] –
Italy – Multicentric
hospital-based series
1998, April + 100 m JCIH, 2000 3 hospitals Bothe 1; 2; 3 30 dB nHLd; unilateral Technician Silent room











6 Habib H, 2005 [38] –




JCIH 1994 1 Hospital OAEa 2; 0; 2 26 dB HL; unilateral Technician N.R.
7 Kennedy C, 2005 [39] -
UK - Prospective cohortf
1993, October +
36 m
Ad hoc 4 Hospitals Botha 2; 0; 2 40 dB HL; bilateral Trained nurse N.R.
8 Korres S, 2008 [40] –
Greece - Hospital-based
series
N.R. + N.R. N.R. 1 Hospital OAE 3; 1; 4 40 dB HL; unilateral Audiologist Quite room
9 Lin H, 2007 [41] –
Taiwan - Retrospective
cohort
a) 1998, November +
60 m;
N.R. 1 Hospital a) OAEab) Bothac)
ABRa
a) 2–3; 0; 2–3b) 2; 0; 2c)
2; 0; 2
N.R.; unilateral N.R. N.R.
b) 2004, February +
12 m;
c) 2005, March + 14 m
10 Rohlfs AK, 2010 [42] –
Germany – multicentric
hospital based series
2002 August + 48 m Ad hoc 14 birth clinics and
children hospitals
Both 2; 1; 3 35 dB (aABR); unilateral Trained nurses and
physicians
N.R.
11 Tatli MM, 2007 [43] –
Turkey - Prospective
cohort
2002 + 18 m Ad Hoc 1 University Hospital OAEa 1; 1; 2 N.R.; unilateral N.R. Quite room
12 Tsuchiya H, 2006 [44] –
Japan - Prospective
cohort
1999, July + 64 m N.R. 1 Hospital ABRa 1; 1; 2 35 dB HL (aABR);
unilateral
Technician N.R.
aNo differences for neonates with audiological risk were specified
bWith both automatic and diagnostic ABR
cEquivalent to about 40db HL in voice frequency
ddB nHL = Decibel Normal Hearing
eDiagnostic instead of automatic ABR












Fig. 1 Framework for characterising the screening processes in each study
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nates with 2 day NICU stays, which we felt was suffi-
ciently consistent with the 2007 JCIH recommendations.
Guastini [37] used “staying in NICU for at least 48 h” as
a criterion for increased audiological risk. Conversely,
although Calevo et al. [34] and Rohlfs et al. [42] used
ABR for all higher risk neonates, NICU stays exceed-
ing 5 days were not considered to be a risk factor in
their protocols.
The threshold for defining a positive screening test for
hearing loss varied across studies: 26 [38], 30 [36], 35
[35, 42, 44] or 40 [33, 34, 37, 39, 40] dB HL (Decibel
Hearing Loss) while Lin and collegues [41] and Tatli and
colleagues [43] did not report any threshold. Suspected
hearing loss required unilateral involvement in eleven
studies [33–38, 40–44] and bilateral involvement in one
[39]. The criteria for defining the presence of hearing
loss at definitive audiological evaluation was identical
to that used in the screening phase in all studies ex-
cept in Kennedy [39]. In this study, due to the high
rates of positive unilateral screening test results in
neonates < 48 h old measured in the first year of the
programme, the unilateral criteria for screening was
changed to bilateral involvement.
Testing personnel consisted of technicians in three stud-
ies [36, 38, 44], audiologists in three [33, 37, 40], and
trained physicians/assistants/nurses in three [35, 39, 42]
with no specification in three [34, 41, 43] (Table 2). Test-
ing environmental conditions were reported in seven
[33–37, 40, 43] out of 12 studies (Table 2).Table 3 Overall performance indicator results
ID Source Universality Tim
ID1 ID2 ID
1 Bevilacqua M, 2010 [33] I A I
2 Calevo M, 2007 [34] A A I
3 Cebulla M, 2012 [35] N.R. A N.R
4 De Capua, 2007 [36] I A A
5 Guastini L, 2010 [37] N.R. A I
6 Habib H, 2005 [38] I A N.R
7 Kennedy C, 2005 [39] I A I
8 Korres S, 2008 [40] N.R. I N.R
9 Lin H, 2007 [41] N.R. a) A N.R
b) I
c) A
10 Rohlfs AK, 2010 [42] I I I
11 Tatli MM, 2007 [43] N.R. A N.R
12 Tsuchiya H, 2006 [44] I A N.RResults, aggregated for the three quality aspects, are
summarised in Table 3 and are presented in detail in
Additional file 3: Table S1, Additional file 4: Table S2,
Additional file 5: Table S3 (indicators ID4a and ID4b,
reported in Additional file 4: Table S2, have not been
reported in Table 3). We categorised performance as A
when the benchmark was achieved, I when inadequate,
and N.R. when not reported.
For Universality (Additional file 3: Table S1), one study
[34] achieved the benchmark of 95 % screened in the first
month of life (ID1). Out of the six [33, 36, 38, 39, 42, 44]
that failed to meet that standard, one study had a 66.5 %
[44] average screening rate (due to a low 38.4 % per-
formance in the first reported year) with the others ran-
ging from 83.2 % [39] to 93.2 % [36]. Five studies
[35, 37, 40, 41, 43] could not be evaluated for this bench-
mark. For follow-up (ID2), ten [33–39, 41] (only protocols with
either OAE or ABR),[43, 44] achieved the 70 % benchmark;
three [40, 41] (only protocol with OAE and ABR), [42] reported
27.1 % [40] to 65.1 % [42] follow-up [39].
For Timely detection (Additional file 4: Table S2),
audiological evaluation completion by 3 months of
age (ID3) could only be assessed with certainty in
one study [36]. Among the remaining eleven, five
[33, 34, 37, 39, 42] reported the age at diagnosis using
criteria that differed from the one recommended by
the JCIH (90th percentile diagnosed by 3 months of
age). Six studies [35, 38, 40, 41, 43, 44] did not report
results on this issue. Overall measured prevalence –
i.e., ID4c – (Additional file 4: Table S2) varied fromely detection Overreferral
3 ID4c ID5 ID6 ID7
0.46 % I A A
0.13 % A A A
. N.R. A A A
0.18 % A A A
0,07 % A A A
. N.R. N.R. A A
0.10 % A A A
. N.R. A A A
. Protocols A Protocols Protocols
a) 0.46 % a) I a) I
b) 0.25 % b) A b) A
c) 0.42 % c) A c) A
0,20 % A A A
. 0.42 % N.R. A A
. N.R. N.R. A A
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lence rates of 1.1 % [37] to 4.89 % [34] for neonates
at higher risk (ID4a) [34, 36, 37], and 0.04 % [37] to
0.68 % [35] (ID4b) for neonates without audiological risk
factors [34–38, 40, 44]. ID4a and ID4b are not reported in
Table 3 but only in Additional file 4: Table S2.
For Overreferral (Additional file 5: Table S3), our
assessment was based on the overall study population
(i.e., neonates either with or without risk factors). It is
important, when reading the indicators, to consider the
mix of the population with respect to risk factors. In
fact, neonates classified as higher risk comprised 1.4 %
to 11.2 % [33, 34, 36, 37, 39] of those screened and can
determine a change in the value of the indicators due to
the different risk of hearing loss within the two popula-
tions. Eight studies [34–37, 39–42] achieved the referral
after hospital discharge benchmark (ID5). This criterion
was not met in one study [33] and was not evaluable in
three [38, 43, 44].
All the studies achieved the referral rate benchmark
for definitive audiological evaluation for all newborn in-
fants who failed initial screening and any subsequent
rescreening – ID6 – (in the case of Lin et al. [41] the
benchmark was not achieved in the protocol using only
OAE). Exactly the same result is verified for the false-
positive rate benchmark (ID7).
Discussion
The purpose of this study was to verify whether litera-
ture data on hospital-based UNHS programmes included
sufficient information to allow inter-programme com-
parisons according to the considered indicators, taken
from available internationally recognised position state-
ments [9, 27, 28], and aggregated according to the pillars
of universality, timely detection and overreferral.
We found that not all studies reported all the data ne-
cessary for calculating the complete proposed set of
quality indicators, and that when comparing available
data on indicators with corresponding benchmarks, the
full achievement of all the recommended targets is an
open challenge.
Additional considerations may be made from the
above-reported results.
We found substantial heterogeneity in the literature
data in the criteria for hearing loss detection (bilateral or
unilateral; threshold – in this case in line with the find-
ing of another systematic review [46]), the criteria for
identifying high-risk neonates, the screening tests used,
the personnel performing the tests, and the environment
in which the tests were carried out.
Two of the benchmarks considered for Overreferral
(ID5 and ID6 in Additional file 5: Table S3) suggest the
proportion of neonates that should be referred after dis-
charge and of those sent for definitive audiologicalevaluation after screening. In clinical practise, achieving
these benchmarks may be adversely affected if an insti-
tution has a high proportion of higher-risk neonates in
its population. Adjustment for case-mix by having separ-
ate benchmarks for the higher- and average-risk popula-
tions would resolve this potential issue. Moreover, these
benchmarks may be affected in cases where neonates
with audiological risk factors are directed to subsequent
steps or to the full audiological evaluation even when
passing a screening test.
Our study confirms the presence of another important
bias in evaluating programme performances, due to the
difficulty in identifying the false negative cases. In fact, this
requires excellent cooperation between health organisa-
tions and the ability to evaluate whether any possible hear-
ing loss identified at a later age has an acquired, late-
onset, progressive aetiology or is a true false negative.
Finally, incomplete follow-up, besides potentially miss-
ing some neonates with hearing loss, may also under- or
over-estimate programme performance by affecting the
age at diagnosis, prevalence, percentage of newborns
eligible for definitive audiological evaluation, and false
positive rate. As reported in Kemper and Downs [47],
although in the United States UNHS has been univer-
sally adopted, a key challenge has been identified in
assuring that screening is consistently administered with
good follow-up and that those identified with hearing
impairment receive effective intervention. Assuring
follow-up after screening is especially difficult [48]. In
fact, in a US survey [49] only 62 % of all newborns with
positive screening tests completed definitive diagnostic
evaluation; of these, only 52 % were evaluated by
3 months of age as recommended by the JCIH. Loss to
follow-up at all stages of the EHDI process also con-
tinues to be a serious concern for the World Health
Organization (WHO) [24], which emphasises the im-
portance of monitoring and implementing all phases of
screening (responsibilities, training, information cam-
paign, procedures of quality assurance). As averred by
the AAP [50] and endorsed by the JCIH [28], EHDI
should include a surveillance phase in which infants up
to 30 months of age undergo monitoring for auditory
skills, middle-ear status, and developmental milestones.
This can lead to earlier detection of hearing loss in in-
fants who had been lost to follow-up, as well as identify-
ing false negatives missed at UNHS.
Our contribution focuses on UNHS programmes. For
this reason we referred only to the subset of the indica-
tors developed by the AAP and JCIH, which since their
statements are focused on EHDI, also allow assessment
of the quality of the diagnostic, treatment and follow-up
processes. A more extensive application of our approach
for the full monitoring of EHDI programmes should
consider this limitation.
Table 4 Reporting checklist
Protocol Section/item Item # Description Reported on
page #/line #
Configuration of hearing loss 1 Identify the target of the screening as unilateral or bilateral.
Severity scale 2 Provide the scale used to classify the degree of hearing loss
(e.g., normal, mild, moderate, and severe)
Threshold dB for hearing loss 3 Provide the dB hearing loss threshold and rationale for that choice
Criteria used for assessing
audiological risks
4 Specify the criteria used to define higher audiological risks
(e.g., the JCIH 2007, admission to NICU, or other criteria)
Protocol for NICUneonates 5 Specify protocol used to screen NICU neonates admitted for more
than 5 days (JCIH recommends automatic auditory brainstem
response – aABR)
Protocol for otherneonates 6 Specify protocol used to screen all the other categories of neonates
Testing environment conditions 7 Describe the environment in which the test is performed (e.g., NICU,
quiet room, mother’s bed)
Definitive audiological evaluation
tests
8 Describe the tests used to perform the definitive audiological examination
as the gold standard for diagnosing hearing loss in neonates who have
positive screening tests
Actions for missed and lost to
follow up
9 Describe the actions performed to re-contact newborns who were missed
or lost to follow-up during one or more screening exam steps
Developmental surveillance and
monitoring
10a Describe any continued hearing surveillance to detect hearing loss in all
children less than 30 months old and all methods used to detect missed
cases of hearing loss during neonatal screening, e.g., due to late onset of
hearing loss or false-negative test results
during screening tests
10b Describe additional methods (beyond those in 10a) used to identify hearing
loss that was undetected (i.e., false negatives) during neonatal screening,
(e.g., information from services providing hearing aids)
10c Describe subsequent developmental monitoring for special populations of
children with hearing loss, including those with minimal and mild bilateral
hearing loss, unilateral hearing loss, and neural hearing loss
Communication 11 Describe all methods used to inform parents about hearing loss screening
and results before, during and after the screening
Health personnel 12 Specify the health personnel performing the screening and their role in each
exam (e.g., physicians for programme coordination and communication with




Recruitment 13 Percentage of newborns who complete screening by 1 month of age
Numerator: Number of neonates that have a hearing screening test by 1 month
of age
Denominator: Number of neonates
Adherence 14 Follow-up rate
Numerator: Number of neonates positive at the first screening test minus
neonates who do not complete further testing (lost to follow-up)




15 Percentage of newborns with definitive audiological evaluation by 3
months of age
Numerator: Number of neonates undergoing definitive audiological
evaluation by 3 months of age
Denominator: Number of neonates undergoing a definitive audiological
evaluation
High-risk measured prevalence 16 Observed prevalence in high-risk population
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Table 4 Reporting checklist (Continued)
Numerator: Number of screened neonates with audiological risk factors
identified with hearing loss after definitive audiological evaluation
Denominator: Number of screened neonates with audiological risk
factors (at net of the lost to follow-up)
Low-risk measured prevalence 17 Observed prevalence in low-risk population
Numerator: Number of screened neonates without any audiological
risk factor identified with hearing loss after definitive audiological
evaluation
Denominator: Number of screened neonates without any audiological
risk factor
(at net of those lost to follow-up)
Overall measured prevalence 18 Observed prevalence for whole population
Numerator: Number of screened neonates (with and without audiological
risk factors) identified with hearing loss after definitive audiological
evaluation
Denominator: Number of screened neonates with or without audiological
risk factors (at net of those lost to follow-up)
C) Overreferral
Referral rate at discharge 19 Referral rate before leaving the hospital
Numerator: Number of screened neonates with a positive test at the last
screening test prior to hospital discharge
Denominator: Number of screened neonates
Referral rate for definitive audiological
Testing after screening
20 Percentage of all newborn infants who fail initial screening and fail all
subsequent re-screening before comprehensive audiological evaluation
Numerator: Number of children completing definitive audiological evaluation
Denominator: Number of screened neonates (at net of the lost to follow-up)
False-positive rate 21 False-positive rate related to the entire screening process
Numerator: Number of neonates who have a negative definitive audiological
evaluation (false-positive screening tests)
Denominator: Number of screened neonates without disease (false positives
plus true negatives or equivalently, number of screened neonates minus the
number of neonates found to truly have hearing loss after definitive audiological
evaluation and minus the number of neonates with hearing loss found negative
at the screening) at net of those lost to follow-up
Mincarone et al. BMC Pediatrics  (2015) 15:86 Page 10 of 12Moreover, it must be considered that the referred
benchmark values are based on expert opinion and that it
is not clear whether achieving or not achieving them dir-
ectly correlates with a threshold where benefits outweigh
any harm of screening or vice versa. An un-reflected
adoption of such benchmarks then seems inadequate.
Another limitation is the restriction to articles
written in English. However, many authors from non-
English-speaking countries often publish in English-
language journals; in the present review all but one
[39] considered studies originating from non-English-
speaking countries.
An additional limitation derives from the fact that the
12 retrieved studies are probably not representative of
the existing UNHS programmes worldwide. This de-
pends on the presence of results not published in peer-
reviewed journals indexed in bibliographic databases,
but issued as reports in the gray literature.Conclusions
As reported in the 2007 JCIH Position Statement [28],
regular measurement of performance and routine monitor-
ing of indicators are recommended for inter-programme
comparison and continuous quality improvement. Fre-
quent assessment of quality permits prompt recognition
and correction of any unstable component of the EHDI
process [51]. Our systematic review of UNHS studies high-
lights substantial variability in programme design and in
reported performance data. In order to optimise reporting
of screening protocols and process performance we
propose a checklist (Table 4). In developing this list, we
have relied on the investigative approach used in our study:
description of the protocol and analysis of the aspects of
quality indicators (Universality,Timely detection, and Over-
referral). Future studies should address the following crit-
ical areas: assessment of long-term outcomes of neonates
with negative screening tests, causes for and interventions
Mincarone et al. BMC Pediatrics  (2015) 15:86 Page 11 of 12to reduce patients lost to follow-up, the standardisation of
recommended quality indicators, and the definition of
evidence-based benchmarks.
Another result inferable from an initial analysis of
available data is the difficulty in guaranteeing full respect
for the criteria of universality, timely detection and over-
referral. Standardisation in reporting UNHS experiences
may also have a positive impact on inter-programme
comparisons, hence favouring the emergence of recog-
nised best practises.
Additional files
Additional file 1: SEARCH STRATEGY – Medline via OVID. The
document reports the search strategy used to retrieve abstracts from
Medline/OVID.
Additional file 2: Figure S1. PRISMA Flow Diagram. The figure reports
a summary of screened articles.
Additional file 3: Table S1. Universality Performance Indicators. The
table describes the detailed evaluations of indicators ID1 and ID2.
Additional file 4: Table S2. Timely detection Performance Indicators.
The table describes the detailed evaluations of indicators ID3, ID4a, ID4b,
ID4c.
Additional file 5: Table S3. Overeferral Performance Indicators. The
table describes the detailed evaluations of indicators ID5, ID6 and ID7.
Abbreviations
aABR: Automatic auditory brainstem response; AAP: American academy of
pediatrics; ABR: Auditory brainstem response; dABR: Diagnostic auditory
brainstem response; EHDI: Early hearing detection and intervention;
JCIH: Joint committee on infant hearing; NICU: Neonatal intensive care unit;
OAE: Otoacoustic emission; UNHS: Universal newborn hearing screening.
Competing interests
The authors declare that they have no competing interests.
Part of the work that led to the present publication was carried out within
the framework of a study funded by the Italian National Center for Disease
Prevention and Control, Ministry of Health: “Cost-effectiveness Evaluation of
Universal Newborn Hearing Screening National Programmes”. In this project,
only ASL Brindisi and the National Research Council-Institute for Research on
Population and Social Policies received funds. The other investigators had no
external funding.
Authors’ contributions
PM conceived and designed the study, reviewed all the titles and abstracts,
read the full text of selected articles, participated in the phase of discussion
on results, drafted the initial manuscript, and approved the final manuscript
as submitted. CGL conceived and designed the study, reviewed all the titles
and abstracts and the full text of selected articles, participated in the phase
of discussion on results, drafted the initial manuscript, and approved the final
manuscript as submitted. SS was responsible for data management,
participated in consensus meetings for addressing discordant evaluations
between the two reviewers, critically reviewed the manuscript, and approved
the final manuscript as submitted. DC participated in consensus meetings for
addressing discordant evaluations between the two reviewers, critically
reviewed the manuscript, and approved the final manuscript as submitted.
FC developed the search strings for each single database, interrogated the
repositories and cleaned from duplicates, participated in consensus meetings
for addressing discordant evaluations between the two reviewers, critically
reviewed the manuscript, and approved the final manuscript as submitted.
JBW critically reviewed the design of the study, participated in the phase of
discussion on results, critically reviewed the work, and approved the final
manuscript as submitted. GL participated in consensus meetings for
addressing discordant evaluations between the two reviewers, participatedin the phase of discussion on results, critically reviewed the manuscript, and
approved the final manuscript as submitted.Acknowledgments
We, the authors, are the only persons responsible for the content of the
article.
Our work has been complemented by the contribution of Marina Cerbo,
Antonella Cavallo, Fabio Bernardini (Italian National Agency for Regional
Healthcare Services - Age.Na.S.) who collaborated on the retrieval of full
papers, Alessandro Montedori (Umbria Region, Italy) who assisted in search
strategy and abstract retrieval, and Roberto Guarino (National Research
Council, Institute of Clinical Physiology) who collaborated on representing
the framework for characterising the screening processes in each study.
Finally, we thank Stephen Pauker (Division of Clinical Decision-Making,
Department of Medicine, Tufts Medical Center, Boston Massachusetts - USA)
for thoughtful methodological suggestions.
Author details
1Institute for Research on Population and Social Policies, National Research
Council, Rome 00185, Italy. 2Institute of Clinical Physiology, National Research
Council, Lecce 73100, Italy. 3Division of Clinical Decision Making, Department
of Medicine, Tufts Medical Center, Boston, MA 02111, USA. 4Newborn
Hearing Screening Service, Azienda USL7 Siena, Siena 53100, Italy. 5Regional
Health Authority of Umbria, Perugia 06124, Italy. 6School of Medicine, Tufts
University, Boston, MA 02111, USA. 7Division of Neonatology, “Perrino”
Hospital, ASL Brindisi, Brindisi 72100, Italy.
Received: 23 September 2014 Accepted: 8 July 2015
References
1. Barsky-Firkser L, Sun S. Universal newborn hearing screenings: a three-year
experience. Pediatrics. 1997;99(6), E4.
2. Mehl AL, Thomson V. The Colorado newborn hearing screening project,
1992–1999: on the threshold of effective population-based universal
newborn hearing screening. Pediatrics. 2002;109(1), E7.
3. Vartiainen E, Kemppinen P, Karjalainen S. Prevalence and etiology of
bilateral sensorineural hearing impairment in a Finnish childhood
population. Int J Pediatr Otorhinolaryngol. 1997;41(2):175–85.
4. U.S. Department of Health and Human Services. Healthy People 2010. In:
With Understanding and Improving Health and Objectives for Improving
Health, vol. 2. 2nd ed. Washington, D.C: U.S. Government Printing Office.
November; 2000.
5. US Center for Diseases Control and Prevention. Summary of 2009 National
CDC EHDI Data. Available at http://www.cdc.gov/ncbddd/hearingloss/
2009-data/2009_ehdi_hsfs_summary_508_ok.pdf.
6. Norton SJ, Gorga MP, Widen JE, et al. Identification of neonatal hearing
impairment: a multicenter investigation. Ear Hear. 2000;21(5):348–56.
7. Arehart KH, Yoshinaga-Itano C, Thomson V, Gabbard SA, Stredler BA. State
of the states: The status of universal newborn screening, assessment, and
intervention systems in 16 states. Am J Audiol. 1998;7:101–14.
8. Harrison M, Roush J. Age of suspicion, identification and intervention for
infants and young children with hearing loss: A national study. Ear Hear.
1996;17:55–62.
9. Erenberg A, Lemons J, Sia C, Trunkel D, Ziring P. Newborn and Infant
Hearing Loss: Detection and Intervention. Pediatrics. 1999;103(2):527–30.
10. Rach GH, Zielhuis GA, van den Broek P. The influence of chronic persistent
otitis media with effusion on language development of 2- to 4-year-olds.
Int J Pediatr Otorhinolaryngol. 1988;15:253–61.
11. Moeller MP, Osberger MJ, Eccarius M. Receptive Language Skills: Language
and Learning Skills of Hearing-Impaired Children, vol. 23. Bethesda, Md:
American Speech, Language and Hearing Association; Monographs of the
American Speech, Language and Hearing Association; 1986. p. 41–53.
12. Allen TE. Patterns of academic achievement among hearing impaired
students: 1974 and 1983. In: Schildroth A, Karchmer AM, editors. Deaf
Children in America. Boston, Mass: College-Hill Press; 1986. p. 161–206.
13. Davis A, Hind S. The impact of hearing impairment: a global health
problem. Int J Pediatr Otorhinolaryngol. 1999;49 suppl 1:S51–4.
14. van Eldik TT. Behavior problems with deaf Dutch boys. Am Ann Deaf.
1994;139(4):394–9.
Mincarone et al. BMC Pediatrics  (2015) 15:86 Page 12 of 1215. Vostanis P, Hayes M, Feu MD, Warren J. Detection of behavioural and
emotional problems in deaf children and adolescents: comparison of two
rating scales. Child Care Health Dev. 1997;23(3):233–46.
16. Thomas MSC, Johnson MH. New advances in understanding sensitive
periods in brain development. Curr Dir Psychol. 2008;17:1–5.
17. Pimperton H, Blythe H, Kreppner J, Mahon M, Peacock JL, Stevenson J,
Terlektsi M, Worsfold S, Ming Yuen H, Kennedy CR. The impact of universal
newborn hearing screening on long-term literacy outcomes: a prospective
cohort study. Arch Dis Child. doi:10.1136/archdischild-2014-307516.
18. Patel H, Feldman M. Universal newborn hearing screening. Paediatr Child
Health. 2011;16(5):301–5.
19. Nelson HD, Bougatsos C, Nygren P, 2001 US Preventive Services Task Force.
Universal newborn hearing screening: systematic review to update the 2001
US Preventive Services Task Force Recommendation. Pediatrics.
2008;122(3):689.
20. Wolff R, Hommerich J, Riemsma R, Antes G, Lange S, Kleijnen J. Hearing
screening in newborns: systematic review of accuracy, effectiveness, and
effects of interventions after screening. Arch Dis Child. 2010;95(2):130–5.
21. Kasai N, Fukushima K, Omori K, Sugaya A, Ojima T. Effects of early
identification and intervention on language development in Japanese
children with prelingual severe to profound hearing impairment. Ann Otol
Rhinol Laryngol Suppl. 2012;202:16–20.
22. Korver AM, Konings S, Dekker FW, et al. DECIBEL Collaborative Study Group.
Newborn hearing screening vs later hearing screening and developmental
outcomes in children with permanent childhood hearing impairment.
JAMA. 2010;304(15):1701–8.
23. McCann DC, Worsfold S, Law CM, et al. Reading and communication skills
after universal newborn screening for permanent childhood hearing
impairment. Arch Dis Child. 2009;94(4):293–7.
24. World Health Organization. Neonatal and infant hearing screening. Current
issues and guiding principles for action. Outcome of a WHO informal
consultation held at WHO head-quarters, Geneva, Switzerland, 9–10
November, 2009. Geneva; WHO. 2010. Available at: http://www.who.int/
blindness/publications/Newborn_and_Infant_Hearing_Screening_Report.pdf
25. Joint Committee on Infant Hearing 1994 Position Statement. American
Academy of Pediatrics Joint Committee on Infant Hearing. Pediatrics.
1995;95(1):152–6.
26. NIH. Early Identification of Hearing Impairment in Infants and Young
Children. NIH Consens Statement. 1993;11(1):1–24.
27. Joint Committee on Infant Hearing. Year 2000 Position Statement: Principles
and Guidelines for Early Hearing Detection and Intervention Programs.
Pediatrics. 2000;106(4):798–817.
28. Joint Committee on Infant Hearing. Year 2007 Position Statement: Principles
and Guidelines for Early Hearing Detection and Intervention Programs.
Pediatrics. 2007;120(4):898–921.
29. O’Donnell NS, Galinsky E. Measuring Progress and Results in Early Childhood
System Development. New York, NY: Families and Work Institute; 1998.
30. Wheeler DJ, Chambers DS. Understanding Statistical Process Control.
Knoxville, TN: SPC Press, Inc.; 1986.
31. Tharpe AM, Clayton EW. Newborn hearing screening: Issues in legal liability
and quality assurance. Am J Audiol. 1997;6:5–12.
32. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, John PA. &
reporting The PRISMA statement for reporting systematic reviews and
meta-analyses of studies that evaluate healthcare interventions : explanation
and elaboration. BMJ Br Med J. 2009. 339:b2700. doi:10.1136/bmj.b2700.
33. Bevilacqua MC, Alvarenga Kde F, Costa OA, Moret AL. The universal
newborn hearing screening in Brazil: From identification to intervention. Int
J Pediatr Otorhinolaryngol. 2010;74(5):510–5.
34. Calevo MG, Mezzano P, Zullino E, Padovani P, Serra G, STERN Group.
Ligurian experience on neonatal hearing screening: clinical and
epidemiological aspects. Acta Paediatr. 2007;96(11):1592–9.
35. Cebulla M, Shehata-Dieler W. ABR-based newborn hearing screening with
MB11 BERAphone1 using an optimized chirp for acoustical stimulation. Int J
Pediatr Otorhinolaryngol. 2012;76(4):536–43.
36. De Capua B, Costantini D, Martufi C, Latini G, Gentile M, De Felice C.
Universal neonatal hearing screening: the Siena (Italy) experience on 19,700
newborns. Early Hum Dev. 2007;83:601–6.
37. Guastini L, Mora R, Dellepiane M, Santomauro V, Mora M, Rocca A, et al.
Evaluation of an automated auditory brainstem response in a multi-stage
infant hearing screening. Eur Arch Otorhinolaryngol. 2010;267(8):1199–205.38. Habib HS, Abdelgaffar H. Neonatal hearing screening with transient evoked
otoacoustic emissions in Western Saudi Arabia. Int J Pediatr
Otorhinolaryngol. 2005;69(6):839–42.
39. Kennedy C, McCann D, Campbell MJ, Kimm L, Thornton R. Universal
newborn screening for permanent childhood hearing impairment: an 8-year
follow-up of a controlled trial. Lancet. 2005;366(9486):660–2.
40. Korres S, Nikolopoulos TP, Peraki EE, et al. Outcomes and Efficacy of
Newborn Hearing Screening: Strengths and Weaknesses (Success or
Failure?). Laryngoscope. 2008;118(7):1253–6.
41. Lin HC, Shu MT, Lee KS, Lin HY, Lin G. Reducing False Positives in Newborn
Hearing Screening Program: How and Why. Otol Neurotol.
2007;28(6):788–92.
42. Rohlfs AK, Wiesner T, Drews H, Müller F, Breitfuss A, Schiller R, et al.
Interdisciplinary approach to design, performance, and quality management
in a multicenter newborn hearing screening project. Introduction, methods,
and results of the newborn hearing screening in Hamburg (Part I). Eur J
Pediatr. 2010;169(11):1353–60.
43. Tatli MM, Bulent Serbetcioglu M, Duman N, et al. Feasibility of neonatal
hearing screening program with two-stage transient otoacoustic emissions
in Turkey. Pediatr Int. 2007;49(2):161–6.
44. Tsuchiya H, Goto K, Yunohara N, et al. Newborn hearing screening in a
single private Japanese obstetric hospital. Pediatr Int. 2006;48(6):604–7.
45. Wessex Universal Neonatal Hearing Screening Trial Group. Controlled trial of
universal neonatal screening for early identification of permanent childhood
hearing impairment. Lancet. 1998;352(9145):1957–64.
46. Olusanya BO, Somefun AO, de Swanepoel W. The Need for Standardization
of Methods for Worldwide Infant Hearing Screening: A Systematic Review.
Laryngoscope. 2008;118(10):1830–6.
47. Kemper AR, Downs SM. Making informed policy decisions about newborn
hearing screening. Acad Pediatr. 2012;12(3):157–8.
48. Russ SA, Hanna D, DesGeorges J, Forsman I. Improving follow-up to
newborn hearing screening: a learning collaborative. Pediatrics.
2010;126:S59–69.
49. Shulman S, Besculides M, Saltzman A, Ireys H, White KR, Forsman I.
Evaluation of the universal newborn hearing screening and intervention
program. Pediatrics. 2010;126 Suppl 1:S19–27.
50. American Academy of Pediatrics, Council on Children With Disabilities,
Section on Developmental Behavioral Pediatrics, Bright Futures Steering
Committee, Medical Home Initiatives for Children With Special Needs
Project Advisory Committee. Identifying infants and young children with
developmental disorders in the medical home: an algorithm for
developmental surveillance and screening. Pediatrics. 2006;118:405–20.
51. Agency for Health Care Policy and Research. Using Clinical Practice
Guidelines to Evaluate Quality of Care: Vol II—Methods. Rockville, MD: US
Department of Health and Human Services, Public Health Service; 1995.
AHCPR publication 95–0046.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
